Reaction profile

The FDA adverse-event record for pr-gastrointestinal parasitism

Name: PR-GASTROINTESTINAL PARASITISM - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

27 FDA reports name pr-gastrointestinal parasitism, a lower-volume reaction in the CVM extract (VeDDRA 99617). Plate stamps and neighbourhood peers follow.

#2044 of 2,481
by report volume (all reactions): 27
reports citing this reaction: 74.1%
death-coded share: Dog
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. PR-GASTROINTESTINAL PARASITISM has 27 reports now versus 27 in that prior snapshot: 0 the same number of (0.0%).

Report change: +0
Death-coded reports: +0
Death-coded share: −0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to PR-GASTROINTESTINAL PARASITISM changes

FDA AER · VeDDRA plate

Code 99617 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 27 reports
DEATH-HOT 74.1%
LOWER-Q #2044/2481
PHOTO-FINISH Abortion spontaneous
SPECIES-DOG Dog · 12
DRUG-LEAD Moxidectin · 3
DESK-WIDE 20 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Abortion spontaneous (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around PR-GASTROINTESTINAL PARASITISM

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around PR-GASTROINTESTINAL PARASITISM

PR-GASTROINTESTINAL PARASITISM: high death-coded share in the FDA AER plate

Signature read: PR-GASTROINTESTINAL PARASITISM's 74.1% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 27 named reports in the openFDA extract. Death-coded share is upper-third: 20 of 27 reports (74.1% of named reports). Nearest volume peer: Abortion spontaneous (±0 reports). Lead species Dog (12). Lead co-reported drug Moxidectin (3).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 12

Cattle 5

Cat 4

Goat 2

Chicken 2

Horse 1

Sheep 1

Breeds Most Affected

Retriever - Labrador 2

Goat (unknown) 2

Boxer (German Boxer) 2

Crossbred Canine/dog 2

Cattle (other) 2

Domestic (unspecified) 1

Horse (unknown) 1

Sheep (unknown) 1

Retriever - Golden 1

Aberdeen Angus 1

Associated Drugs

Moxidectin 3

Doramectin 3

Oclacitinib Maleate 3

Dexmedetomidine Hydrochloride 2

Spinosad 1

Imidacloprid, Moxidectin 1

Ivermectin, Praziquantel 1

Ivermectin, Pyrantel 1

Narasin 1

Carprofen 1

Maropitant 1

Deracoxib 1

Amprolium 1

Hygromycin B 1

Tiletamine Hcl; Zolazapam Hcl 1

Butorphanol 1

Ivermectin/Pyrantel Pamoate Chewable 272Mcg/652Mg 1

Ivermectin/Pyrantel Pamoate Chewable 68Mcg/163Mg 1

Lufenuron + Milbemycin Oxime 1

Ivermectin 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for PR-GASTROINTESTINAL PARASITISM (#2044 of 2,481 by report volume); death-coded 74.1%. PlainBreed reaction plate · death-coded share stamp 74.1% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →